Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared With Usual Standard of Care on Left Ventricular Mass Index in Participants With Fabry Disease and Left Ventricular Hypertrophy (CARAT)

alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.

migalastat
ventricular hypertrophy
agalsidase alfa
hypertrophy
agalsidase beta
  • 1 views
  • 22 Sep, 2022
  • 8 locations
A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared With Usual Standard of Care on Left Ventricular Mass Index in Participants With Fabry Disease and Left Ventricular Hypertrophy (CARAT)

alfa, agalsidase beta, or migalastat) to evaluate the effect of venglustat on left ventricular mass index (LVMI) in adult participants with Fabry disease and left ventricular hypertrophy.

migalastat
ventricular hypertrophy
agalsidase alfa
hypertrophy
agalsidase beta
  • 0 views
  • 23 Sep, 2022
  • 12 locations
A Phase 3, Open-label Study to Evaluate the Efficacy and Safety of REPLAGAL® in Treatment-naïve Subjects With Fabry Disease

In this study, adults with Fabry Disease who have not had any treatment for this condition will be treated with Replagal. The main aim of the study is to check if Replagal improves kidney

hypertrophy
deficit
deficiency
replagal
ventricular hypertrophy
  • 0 views
  • 19 Aug, 2022
  • 2 locations
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI (FIESTA-MRI)

This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase

cardiomyopathy
  • 0 views
  • 18 Sep, 2022
  • 1 location
Fabry Disease Registry Protocol

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment

deficiency
alpha-galactosidase
replacement therapy
agalsidase beta
deficit
  • 2 views
  • 09 Sep, 2022
  • 232 locations
Fabry Disease Registry Protocol

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment

deficiency
fabrazyme
replacement therapy
agalsidase beta
deficit
  • 460 views
  • 19 Sep, 2022
  • 237 locations
NeuroVascular Product Surveillance Registry (PSR) Platform (INSPIRE)

Post market surveillance registry

stroke
embolization procedure
  • 922 views
  • 21 Sep, 2022
  • 58 locations
Taiwan Associated Genetic and Nongenetic Small Vessel Disease (TAG-SVD)

The TAG-SVD enrolled patients with clinical and neuroimaging features of cerebral small vessel disease (CSVD). All enrolled patients will receive next-generation sequence (NGS) with probes designed to target five candidate CSVD genes, and patients will be divided into genetic or non-genetic groups accordingly. Their clinical features and outcome will be …

Accepts healthy volunteers
  • 0 views
  • 10 Aug, 2022
  • 1 location